CHMP recommends Novartis drug AfinitorR for EU approval marking major ... Reuters Basel, June 22, 2012 - Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Afinitor R (everolimus) tablets*, in combination with exemestane ... Novartis: CHMP Recommends Afinitor For EU Approval In Advanced Breast ... Novartis: EU Backs Afinitor in Breast Cancer Novartis Says CHMP Recommends Afinitor For EU Approval - Quick Facts |
